Neck circumference for predicting the occurrence of future cardiovascular events: A 7.6-year longitudinal study-Reference-Cited by-同舟云学术

Neck circumference for predicting the occurrence of future cardiovascular events: A 7.6-year longitudinal study

Published:2022-12 Issue:12 Volume:32 Page:2830-2838
ISSN:0939-4753
Container-title:Nutrition, Metabolism and Cardiovascular Diseases
language:en
Short-container-title:Nutrition, Metabolism and Cardiovascular Diseases

Author:

Hu Tingting,Shen Yun,Cao Weijie,Xu Yiting,Wang Yufei,Ma Xiaojing,Bao Yuqian

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Reference38 articles.

1. Global burden of cardiovascular diseases and risk factors, 1990-2019;Roth Gregory;J Am Coll Cardiol,2020

2. Key points of report on cardiovascular health and diseases in China 2020;Chin J Cardiovas Rev,2021

3. Geographical variations in cardiovascular health in China: a nationwide population-based survey of 74,726 adults;Zhang;Lancet Reg Health West Pac,2020

4. Obesity and cardiovascular disease: a scientific statement from the American Heart Association;Powell-Wiley;Circulation,2021

5. Introduction to the obesity, metabolic syndrome, and CVD compendium;Moore;Circ Res,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between physical activity and neck circumference with cardiovascular disease risk in older wheelchair users;Journal of Rehabilitation Medicine;2024-06-19

2. Utiliser des marqueurs anthropométriques et biologiques simples;La Presse Médicale Formation;2024-04

3. Neck circumference as an additional predictor of cardiovascular disease mortality: A multi-center prospective population-based study in northeastern China;Preventive Medicine;2024-03

4. Neck circumference as a predictor of all-cause mortality in middle-aged and older adults in rural Ecuador;International Health;2024-01-17

5. Insight to the association among fibroblast growth factor 21, non-alcoholic fatty liver disease and cardiovascular outcomes: A population-based study;Cytokine;2023-10